2Indexed trials
drug · Product Intelligence
Amantadine
Pipeline Intelligence
Amantadine: 2 indexed trials, 2 sponsors; 13 linked Orange Book patents and 19 FDA-linked events where matched.
2Sponsors
13Orange Book patent links
19FDA-linked events
Development evidence
NCT01190553Rabin Medical Center · parkinsonsNA
NCT07113015Multan Medical And Dental College · parkinsonsNA
FDA / patent evidence
11077073GOCOVRI · app 2089442038-08-23
12233033GOCOVRI · app 2089442038-08-23
11065213GOCOVRI · app 2089442038-08-23
10154971GOCOVRI · app 2089442034-12-04
10646456GOCOVRI · app 2089442034-06-17
11903908GOCOVRI · app 2089442034-06-17
9877933GOCOVRI · app 2089442030-12-02
11197835GOCOVRI · app 2089442030-12-02
8741343GOCOVRI · app 2089442030-12-02
9867791GOCOVRI · app 2089442030-12-02
9867792GOCOVRI · app 2089442030-12-02
9867793GOCOVRI · app 2089442030-12-02
Regulatory context
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2024-09-26
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2024-08-26
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2022-12-20
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2022-05-27
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2020-10-15
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2020-05-21
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2018-02-07
FDA_APPROVALGOCOVRI · 2017-08-24
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2017-06-15
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2017-06-12
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2016-05-31
FDA_APPROVALAMANTADINE HYDROCHLORIDE · 2008-05-29
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.